Tan Marcus Chun Jin

Two-Year Outcomes of the Paul Glaucoma Implant for Treatment of Glaucoma.

The PGI was able to achieve sustained IOP reduction with reduction of medications at 2 years postsurgery in patients with advanced glaucoma.

Three-Year Outcomes of the Paul Glaucoma Implant for Treatment of Glaucoma.

The PGI demonstrated sustained IOP reduction and a reduction of medication burden at 3 years postoperatively.

Outcomes of Stent Removal in Eyes With the Paul Glaucoma Implant With Intraluminal 6-0 Polypropylene.

Less than half of the eyes with PGI stented with intraluminal 6-0 polypropylene required stent removal.

Clinical Efficacy and Safety of the PAUL Glaucoma Implant: A Systematic Review and Meta-Analysis.

This meta-analysis provides quantitative evidence supporting the clinical efficacy and safety of the PGI in patients with refractory glaucoma.